{
    "code": "01026322",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01026322",
    "time": "2020-02-25 05:02:35",
    "許可證字號": "衛署藥製字第026322號",
    "註銷狀態": "已註銷",
    "註銷日期": "97\/09\/23",
    "註銷理由": "未依公告辦理變更",
    "有效日期": "97\/05\/25",
    "發證日期": "71\/09\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102632201",
    "中文品名": "&quot;國信&quot;立舒注射液 25 毫克 \/ 毫升",
    "英文品名": "Difenac Injection 25mg\/ml &quot;K.S.&quot;",
    "適應症": "下列疾患及症狀之鎮痛、消炎：慢性風濕性關節炎、變形性關節炎及脊椎症、腰痛症、腱鞘炎、頸肩腕症候群、神經痛、手術後之鎮痛、消炎",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 09委託製造",
        "申請商名稱": "1101417200  國信藥品股份有限公司",
        "申請商地址": "嘉義巿南興路２２２號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808400410",
            "成分名稱": "DICLOFENAC SODIUM",
            "含量描述": "25",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010263220001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01026322&Seq=001&Type=9"
        }
    ]
}